Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Crunchfish launches partner strategy for Digital Cash

An ecosystem for Digital Cash Partners will be very important in the commercialization of Crunchfish’s Digital Cash  solutions. By cooperating with partners within complementing fields of technology, Crunchfish opens up marketing channels, new geographical markets and strategic customer segments. With some partners already in place, Crunchfish now defines an ecosystem for Digital Cash with the purpose to quickly scale up sales and get a global spread of the company’s solutions.Crunchfish’s Digital

Invitation to DNB’s extended fourth quarter presentation, Wednesday, 10 February 2021

DNB will publish its results for the fourth quarter of 2020 on Wednesday, 10 February 2021 at 07.30 CET. The fourth quarter results will be presented at 9:30-11:30 CET the same day, at an extended presentation which will also include an update on dividends, strategic topics, status on financial ambitions, and presentations from the customer segments. The event will be webcasted, and it will be possible to ask questions online. Link to webcast will be made available at ir.dnb.no. Agenda: · Kjerstin Braathen (CEO) · Ottar Ertzeid (CFO) · Harald Serck-Hanssen (Group EVP

New US patent approval for Episurf Medical

Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled “Design of an implant for cartilage repair”, relates to Episurf Medical’s design processes for individualised design and has a focus on a surgical instrument for inserting the company’s Episealer® implants accurately. “This is the first approval in this patent family, giving us protection in the area of individualised design of surgical devices. Through our design processes we create medical devices with the best possible fit for each

Recently opened restaurant in Oslo invests in environmentally friendly solutions together with Kiilto

The past 12 months have been a tough for the restaurant industry. However, Brasilia opened its new grill restaurant in Oslo, Norway on December 1 and takes hygiene and infection control very seriously during the on-going COVID-19 pandemic. Brasilia, which also has a restaurant in Bergen, has chosen Kiilto as the total supplier of cleaning and disinfectant products from the brands Kiilto Pro and Antibac.The world's best restaurants have an impeccably clean kitchen. It is an indicator of the restaurant’s food standards and shows that the restaurant's staff values high quality in their work.

Norway Royal Salmon (NRS): Selected preliminary Q4 figures for Arctic Fish ehf.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Arctic Fish ehf ("Arctic Fish"), a company owned 50 % by Norway Royal Salmon (NRS), harvested 2 988 tonnes (HOG) during the fourth quarter of 2020, resulting in a total harvest of 7 443 tonnes (HOG) for 2020.  Arctic Fish expects to harvest

Adverty and Verizon Media announce new deal to enable a huge range of brands and audiences to access Adverty’s innovative ad formats within gaming

Adverty AB (publ) today announces a new deal with global media and technology company Verizon Media, a division of Verizon Communications Inc., which houses a trusted media ecosystem of premium brands and industry-leading technology platforms. The integration of Adverty’s platform will enable Verizon Media’s wide range of advertisers and audiences to access Adverty’s seamless ad inventory at scale.Adverty will connect to Verizon Media’s Sell-Side Platform (SSP), enabling its unique and unobtrusive ad offering to reach wider audiences within gameplay, to maximise brand exposure and publisher

AKER ASA: Aker Horizons, Aker Offshore Wind enter cooperation agreement with Statkraft

Aker ASA (“Aker”) today announced that its wholly owned subsidiary, Aker Horizons AS (“Aker Horizons”), and Aker Offshore Wind Operating Company AS (“Aker Offshore Wind”) have entered into a cooperation agreement with Statkraft AS (“Statkraft”) to explore possibilities for collaboration on offshore wind power projects on the Norwegian Continental Shelf (“NCS”).Aker Horizons, Aker Offshore Wind and Statkraft (the “Parties”) will work together and utilize their complementary skills and expertise to explore the possibility to develop and operate large-scale offshore wind parks in Norway. By

AKER ASA: Aker Horizons strengthens renewables portfolio with entry into hydropower

Aker ASA (“Aker”) announced today that its wholly owned subsidiary Aker Horizons AS (“Aker Horizons”) has entered into an agreement to acquire Rainpower Holding AS (“Rainpower”). Aker Horizons will use Rainpower as a platform to build a next generation technology company to optimize hydropower developments and operations.“Aker Horizons is continuing its planet-positive investing, making strides towards developing a growth platform of integrated renewable technologies with positions in onshore and offshore wind and solar. With increasing demand for power market flexibility and storage

YIT becomes a service operator for business premises

The first Workery+ will open in Vallila in the spring with the aim of creating a network of business premises in the Helsinki metropolitan area. The new situation caused by the COVID-19 pandemic has prompted companies to consider how the ways of working will be reshaped once the worst is over. Can any company predict how much space they need now that remote working is here to stay? YIT is introducing a new concept called Workery+ to the business premises market, combining best practices from both traditional office rental and coworking spaces. “Our first location in Vallila,

NENT Group tops Nordic Business Diversity Index

· NENT Group ranked number one in Stockholm Nasdaq Large Cap Companies and TMT (all Nordics) categories · Nordic Business Diversity Index measures diversity of boards and executive management · NENT Group has a 50/50 gender split in senior leaders reporting to CEO Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, has been ranked number one in the Nordic Business Diversity Index in both the Stockholm Nasdaq Large Cap Companies and TMT (all Nordics) categories. The Nordic Business Diversity Index measures the diversity of boards and executive

BioArctic receives European patent for new antibodies targeting Alzheimer’s disease

Stockholm, January 27, 2021 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the European Patent Office (EPO) has issued a decision to grant European patent EP 2 448 968 B1 for novel antibodies that could be developed into a treatment for Alzheimer’s disease. The antibodies target a shorter (truncated) form of amyloid beta (pE3-Aβ) and are linked to the company’s project AD1503. The patent enters into force on 27 January 2021 and expires in 2030. BioArctic’s newly granted patent focuses on novel antibodies which target pE3-Ab, a specific truncated form of amyloid

Proposal regarding the Board of Directors

Castellum has received a proposal regarding the composition of the Board of Directors from Stichting Pensioenfonds ABP, the second largest shareholder in Castellum, and two members of the Election Committee, Vincent Fokke, representing Stichting Pensioenfonds ABP, and Charlotte Strömberg, Chair of the Board of Castellum. The election of the Board of Directors will take place at the Annual General Meeting to be held on March 25, 2021.Proposal regarding the composition of the Board The purpose of this proposal is to ensure a Board of Directors of Castellum that is both competent and

SBB increases focus on housing for the elderly

Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) intends to double the value of properties for housing for the elderly in the Nordic region within two years to approximately SEK 20 billion. In the current property portfolio, the Swedish tenants are 75 per cent public actors with an average lease period of just over seven years. As part of the acquisition of Sveafastigheter, Magnus Edlund will transfer to SBB in a new role as Head of Business Development for Elderly Care Housing. Magnus has over 30 years of experience from the real estate industry in senior positions with institutional

Q-Free: Acceptances received under mandatory offer to acquire all shares in Q-Free ASA

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the Offer, the distribution of this stock exchange announcement or the acceptance of any tender of shares would contravene applicable laws or regulations. (Oslo, 27 January 2021): Reference is made to the mandatory offer (the “Offer”) from Rieber & Søn AS (the “Offeror”) to acquire all shares in Q-Free ASA (“Q-Free” or the “Company”) pursuant to an offer document

Orexo strengthens IP rights for overdose rescue drug OX124

· Patent protection until 2039 · Previous human pharmacokinetic (PK) study showed significantly better PK profile when compared to market leading product Uppsala, Sweden – January 27, 2021 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that the company has further strengthened the intellectual property (IP) for its flagship pharmaceutical pipeline asset OX124, a naloxone rescue medication for the treatment of opioid overdose. The US Patent and Trademark Office (USPTO) has issued a new patent protecting the product until 2039. The new patent, US 10,898,480, is the

Hansa Biopharma to host conference call to provide Year-End report 2020 and Business Update

Lund, Sweden January 27, 2021. Hansa Biopharma will publish its Year-End report 2020 at 8:00 CET on February 4, 2021. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET/2:00pm EST. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English. Slides used in the presentation will be live on the company website during the call under “Events & Webcast,” and will also be made

Increased sales and profitability in 2020 during a challenging fourth quarter

January - December · Net sales increased +0.8 percent to SEK 310.1 (307.6) million (+3 percent in local currencies). · EBIT was SEK 28.6 (6.2) million. · The EBIT margin was 9.1 (2.0) percent. · Profit after tax amounted to SEK 16.3 (4.9) million. · Earnings per share before/after dilution amounted to SEK 0.88 (0.28). · Cash flow from operating activities amounted to SEK 52.0 (17.7) million. · Cash and cash equivalents at the end of the period amounted to SEK 101.2 (63.9) million. Fourth quarter · Net sales declined -20.6 percent to SEK 66.7 (84.0) million (-

Divio announces that an additional contract for a Support Service Level Agreement is signed with Fidelity International

Divio Technologies AB (publ) today announced that investment and retirement savings provider Fidelity International has increased its engagement with Divio. This additional commitment takes the form of a Support Service Level Agreement, and entails an additional recurring monthly revenue of USD 43’200.Divio has enjoyed a long-term relationship with Fidelity International, a partnership that has strengthened and deepened over the years. As well as its adoption of Divio’s cloud management platform, Fidelity International uses Divio as a strategic technology partner providing expertise. In

Nationalarenan 3 – Scandinavia’s first ‘Plushus’ hotel

Scandinavia’s first zero-energy hotel, Nationalarenan 3 in Arenastaden, is now in the final stages of completion. The building produces as much energy as it consumes, and has now achieved FEBY ‘Gold Plushus’ certification. FEBY’s purpose as an organisation is to increase and develop energy-efficient construction.Nationalarenan 3 is a unique project that aims to meet ambitious sustainability targets, while calling on the industry as a whole to build more sustainably. Some 25 geothermal energy boreholes along with a total of almost 2,500 sqm of solar panels on the facade and roof produce more

Delete Group Oyj announces status and tentative timeline of the restructuring measures

Delete Group Oyj, Stock Exchange Release 27 January 2021 at 8.30 EETNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. As announced by Delete Group Oyj ("Delete" or the "Issuer") on 16 December 2020, Delete has, together with its financial adviser, ABG Sundal Collier ASA, initiated certain restructuring measures (the "Restructuring Measures"). On 15 January 2021, Delete announced that the holders of its secured fixed rate notes due 2021 (ISIN

SEB revises financial targets to support customers through increased financial flexibility

SEB’s Board of Directors has revised the financial targets for the group, with the objective to create further financial flexibility to better support the bank’s customers over time. According to the new targets, the bank will maintain a Common Equity Tier 1 capital ratio of 100-300 basis points above the regulatory requirement and pay a yearly dividend of around 50 per cent of earnings per share, and distribute potential capital in excess of the targeted capital position mainly through share repurchases.SEB’s financial targets, with effect from 2021, are: · To pay a yearly dividend

BERGENBIO ASA: INVITATION TO FOURTH QUARTER 2020 RESULTS

Bergen, Norway, 27 January 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, will be announcing its results for the fourth quarter 2020 on Wednesday 10 February 2021. A webcast presentation by BerGenBio’s senior management team will take place at 10:00 am CET.  The live webcast link will be available at www.bergenbio.com in the Investors/Financial Reports section. A recording will be available shortly after the webcast has finished.  The fourth quarter report and presentation

Year-end Report 2020

JANUARY 1 – DECEMBER 31, 2020(compared with the corresponding period a year ago) · Highest adjusted EBITA and highest adjusted EBITA margin ever · Target raised for adjusted return on capital employed to above 17% by 2025 · Net sales declined 5.6% to SEK 121,752m (128,975) · Organic net sales declined 1.9% · Sales were negatively impacted by the COVID-19 pandemic and related lockdowns · In emerging markets, which accounted for 37% of net sales, organic net sales increased 2.6% · Operating profit before amortization of acquisition-related intangible assets (EBITA)

There are no items matching the current filter
There are no more items matching the current filter
Back to top